Disease-Modifying Drugs for Multiple Sclerosis Must Be Globally Available According to Therapeutic Guidelines Suitable to Different Regions of the World

AuthID
P-00J-2EE
1
Author(s)
Tipo de Documento
Article
Year published
2012
Publicado
in Arq. Neuro-Psiquiatr. - Arquivos de Neuro-Psiquiatria, ISSN: 0004-282X
Volume: 70, Número: 10, Páginas: 761-762
Indexing
Publication Identifiers
Source Identifiers
ISSN: 0004-282X
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.